Pharma

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

Edited by Nirmalya Sen | Tuesday February 16, 2021

WHO's move widens access to the relatively inexpensive shot in the developing world

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

Revenue for the third quarter came at Rs 4,930 crore, which was up 12 per cent year-over-year and 1 per cent quarter-over-quarter

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Edited by Nirmalya Sen | Friday January 29, 2021

Serum Institute Of India has applied to conduct local trial for Novavax vaccine

Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait

Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait

Edited by Nirmalya Sen | Wednesday January 27, 2021

Fujifilm, Dr. Reddy's and GRA had entered into a deal in July to sell Avigan globally excluding Japan, China and Russia

Moderna Believes Vaccine Will Work Against New Variants

Moderna Believes Vaccine Will Work Against New Variants

Edited by Nirmalya Sen | Tuesday January 26, 2021

Moderna Covid-19 Vaccine: The emergence of new variants in Britain, South Africa and Brazil has created some concern that mutations in the virus may make vaccines less effective

Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil

Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil

Edited by Nirmalya Sen | Friday January 22, 2021

The announcement comes amid delays in receiving the vaccine from India, the latest in a series of miscues surrounding the country's inoculations drive

India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil

India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil

Edited by Nirmalya Sen | Friday January 22, 2021

Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia

South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII

South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII

Edited by Nirmalya Sen | Thursday January 21, 2021

South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying

Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon

Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon

Edited by Nirmalya Sen | Thursday January 14, 2021

The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly lagging Western countries

Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial

Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial

Edited by Nirmalya Sen | Monday January 11, 2021

The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials

AstraZeneca's Covid-19 Vaccine Set To Become First One Approved In India: Report

AstraZeneca's Covid-19 Vaccine Set To Become First One Approved In India: Report

Edited by Nirmalya Sen | Friday January 01, 2021

Britain and Argentina have already authorised the vaccine for urgent public use

Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients

Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients

Edited by Nirmalya Sen | Wednesday December 30, 2020

Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity

India Dry Runs Vaccine Delivery Systems Ahead Of Emergency Approval

India Dry Runs Vaccine Delivery Systems Ahead Of Emergency Approval

Edited by Nirmalya Sen | Monday December 28, 2020

Covid-19 Vaccine: India aims to deliver 600 million coronavirus shots over the next six to eight months starting in January

Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials

Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials

Edited by Nirmalya Sen | Friday December 25, 2020

Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction

12345...6